Related by context. Frequent words. (Click for all words.) 72 DSMB 66 dose escalation 65 Phase 2b study 64 Phase 1b 63 randomized 63 Phase Ib 62 placebo controlled 61 Phase III pivotal 61 Phase 2b clinical 61 Phase IIb trial 60 Phase 2a clinical 60 Phase 2a 59 clinical trial 59 Phase IIb 59 Phase IIa trial 58 Phase IIa 58 Phase 2b trial 58 pivotal Phase 58 Phase III clinical 58 dose escalation study 58 randomized placebo controlled 58 randomized Phase 57 randomized controlled 57 randomization 57 multiple ascending dose 57 Phase IIa clinical 57 randomized clinical trials 57 sunitinib 57 vandetanib 57 Phase IIb clinical 56 blind randomized 56 evaluable patients 56 prospective randomized 56 Phase 2b 55 pivotal Phase III 55 multicenter 55 Phase III 55 mg dose 55 randomized clinical 55 bevacizumab 55 evaluable 55 T DM1 55 dasatinib 54 Zerenex 54 free survival PFS 54 randomized double 54 primary endpoint 54 primary efficacy endpoint 54 non inferiority 54 ASA# 54 letrozole 54 FOLFOX 54 mg BID 54 pemetrexed 54 secondary endpoint 54 randomized trials 53 Phase III trials 53 IMGN# 53 adjuvant therapy 53 blind randomized placebo 53 dosing regimens 53 pharmacodynamics 53 pharmacokinetic 53 pharmacodynamic 53 monotherapy 53 tolerability 53 TMC# [001] 53 ONGLYZA 53 LibiGel 53 dose limiting toxicities 53 pegylated interferon 52 RCTs 52 primary endpoints 52 PRX # 52 double blind placebo 52 rosuvastatin 52 angiographic 52 rivaroxaban 51 panitumumab 51 AP# [003] 51 randomized controlled trials 51 ZYBRESTAT 51 RG# [001] 51 docetaxel 51 clinical trials 51 Phase III clinical trials 51 relapsing remitting multiple sclerosis 51 HbA1c levels 51 post hoc 51 daclizumab 51 Phase II 51 FTY# 51 JANUVIA 51 adjuvant chemotherapy 51 satraplatin 51 prospective cohort 51 LEVADEX 51 INCB# [002] 50 dosing 50 sitagliptin 50 reach statistical significance